30.36
-0.03 (-0.10%)
| Previous Close | 30.39 |
| Open | 30.82 |
| Volume | 957,222 |
| Avg. Volume (3M) | 809,687 |
| Market Cap | 1,493,353,728 |
| Price / Earnings (TTM) | 92.00 |
| Price / Earnings (Forward) | 625.00 |
| Price / Sales | 4.51 |
| Price / Book | 3.65 |
| 52 Weeks Range | |
| Earnings Date | 30 Oct 2024 - 4 Nov 2024 |
| Profit Margin | 4.99% |
| Operating Margin (TTM) | 12.08% |
| Diluted EPS (TTM) | 0.330 |
| Quarterly Revenue Growth (YOY) | 7.30% |
| Quarterly Earnings Growth (YOY) | 21.70% |
| Total Debt/Equity (MRQ) | 8.87% |
| Current Ratio (MRQ) | 5.80 |
| Operating Cash Flow (TTM) | 37.26 M |
| Levered Free Cash Flow (TTM) | 22.24 M |
| Return on Assets (TTM) | 3.66% |
| Return on Equity (TTM) | 4.36% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | STAAR Surgical Company | Bearish | Bearish |
Stockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.63 |
|
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 0.53% |
| % Held by Institutions | 93.39% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Defender Capital, Llc. | 30 Jun 2024 | 649,187 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 44.00 (Stifel, 44.93%) | Buy |
| Median | 37.50 (23.52%) | |
| Low | 31.00 (Canaccord Genuity, 2.11%) | Hold |
| Average | 37.50 (23.52%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 30.63 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Canaccord Genuity | 01 Nov 2024 | 31.00 (2.11%) | Hold | 28.56 |
| Stifel | 26 Aug 2024 | 44.00 (44.93%) | Buy | 32.69 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 13 Nov 2024 | Announcement | STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024) |
| 30 Oct 2024 | Announcement | CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results |
| 23 Oct 2024 | Announcement | STAAR Surgical to Report Third Quarter Results on October 30, 2024 |
| 23 Sep 2024 | Announcement | STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand |
| 17 Sep 2024 | Announcement | Sidoti Events, LLC's Virtual September Small-Cap Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |